Navigation Links
Industry and academic researchers gather for innovative accelerating cancer cures research symposium
Date:3/4/2013

Cambridge, MA (March 4, 2013) Today, the Damon Runyon Cancer Research Foundation held its annual Accelerating Cancer Cures Research Symposium designed to foster communication and collaboration between cancer researchers in industry and academia to speed progress against cancer. Hosted by Millennium: The Takeda Oncology Company, the meeting included physician-scientists from Eli Lilly and Company, ARIAD, Celgene, Genentech, Merck, and Pfizer, as well as academic researchers from the top universities and research institutions in the nation.

Accelerating Cancer Cures is a unique collaboration between Damon Runyon, a prestigious cancer charity that supports the most innovative young cancer researchers, and leading biopharmaceutical companies. The goal of this multi-million dollar initiative is to rebuild the ranks of specially trained physician-scientists who conduct both the cutting-edge laboratory research to identify new therapeutics, as well as the clinical trials to bring these new treatments to patients. The companies involved in this initiative, while competitors in the marketplace, are committed to supporting the best young clinical investigators so that they can drive the next breakthroughs in cancer prevention, diagnosis and treatment.

The President and CEO of Millennium, Dr. Deborah Dunsire, opened the meeting with remarks that focused on the need for greater collaboration between industry and academia. Additionally, David Nathan, MD, President Emeritus, Dana-Farber Cancer Institute, and the Robert A. Stranahan Distinguished Professor of Pediatrics and Professor of Medicine, Harvard Medical School, delivered a keynote address about the promise of cancer research and the critical role of patient-oriented physician-scientists in advancing progress against the many forms of cancer. Richard B. Gaynor, MD, Vice President, Cancer Research/Clinical Investigation, of Lilly, and Alan Leventhal, Chairman and CEO of Beacon Capital Partners and Chairman of the Board of the Damon Runyon Cancer Research Foundation, also spoke about this groundbreaking collaboration.

"It is extraordinary that industry competitors have come together to address a major obstacle to developing new treatments for cancer patients," said Damon Runyon Cancer Research Foundation President and CEO, Lorraine Egan. "Through Accelerating Cancer Cures, we are ensuring that the best young physician-scientists can continue to be the critical link between the research lab and the patients."

"The future of oncology research and the creation of novel treatments rests in the hands of talented scientific leaders like those who are presenting at this year's Accelerating Cancer Cures symposium, which Millennium is proud to host," stated Dr. Karen Ferrante, Chief Medical Officer, Millennium: The Takeda Oncology Company. "This event underscores the importance of collaboration between the biopharmaceutical industry and its academic partners, and how these partnerships will ultimately create new cancer treatments for patients."

Scientists from the nation's leading research institutions, including the Dana-Farber Cancer Institute, Memorial Sloan-Kettering Cancer Center, Fred Hutchinson Cancer Research Center, Stanford University, the University of Texas MD Anderson Cancer Center, and the University of North Carolina, Chapel Hill, attended the symposium to hear presentations on a diverse range of promising research, from advances in colorectal cancer detection to novel therapeutic approaches to breast cancers, and to brainstorm about new approaches to speed new treatments to cancer patients.


'/>"/>
Contact: Yung S. Lie
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Related medicine news :

1. MSU invention could help pharmaceutical industry save money
2. More cutting-edge cancer research supported by industry
3. Ultra-short laser pulses for science and industry
4. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
5. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
6. Advertising Industry Veteran Pat McCrossan Joins Mangos
7. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
8. QTrade's New Facility Anticipates Dramatic Growth of Tea Industry
9. A Void In The Independent Pharmacy Industry Leads to Independent Rx Consulting, Powered by OurHelix
10. Massage Industry Heavyweights Team Up for First-Ever Massage Documentary
11. Butter flavoring in microwave popcorn, thought safe for food industry workers, is respiratory hazard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: